Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 294877-29-5 | MDL No. : | MFCD11845717 |
Formula : | C11H11BrN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KPIAAVHCRHKNRT-UHFFFAOYSA-N |
M.W : | 251.12 | Pubchem ID : | 22980805 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.18 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 61.2 |
TPSA : | 17.82 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.43 cm/s |
Log Po/w (iLOGP) : | 2.76 |
Log Po/w (XLOGP3) : | 3.38 |
Log Po/w (WLOGP) : | 3.25 |
Log Po/w (MLOGP) : | 3.01 |
Log Po/w (SILICOS-IT) : | 3.1 |
Consensus Log Po/w : | 3.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.04 |
Solubility : | 0.0228 mg/ml ; 0.0000908 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.43 |
Solubility : | 0.0927 mg/ml ; 0.000369 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.56 |
Solubility : | 0.00695 mg/ml ; 0.0000277 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.06 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59% | With sulfuric acid In dichloromethane at 20℃; for 16 h; Inert atmosphere | A solution of (3-bromophenyl)hydrazine hydrochloride (available from Reddy & Reddy) (45 g, 200 mmol) and pentane-2,4-dione (Aldrich) (30.2 g, 302 mmol) in DCM (225 mL) was treated dropwise with cone. H2S04 (1.073 mL, 20.13 mmol) and stirred under nitrogen at room temperature for 16 h. The reaction mixture was diluted with DCM (500 mL), and washed with water (2 x 250 mL). The organic layer was dried over Na2S04 and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (100-200 mesh) eluting with 5percent ethyl acetate in hexanes to give the title compound ( 0 g, 59percent) as a light brown liquid: H NMR δ (CDCI3, 400 MHz) 7.71 (t, 7=2 Hz, 1H), 7.57 - 7.49 (m, 2H), 7.46 - 7.40 (t, 7=8 Hz, 1H), 6.07 (s, 1H), 2.31 (s, 3H), 2.18 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | at 65℃; for 6 h; | In a 50 mL reaction flask 3-bromophenylhydrazine 2 (1.40 g, 7.5 mmol) was added,Acetylacetone 3a (1.00 g, 10.0 mmol) and 10 mL of ethanol were added and the reaction was stirred at 65 ° C for 6 hours. anti- At the end of this time, the mixture was allowed to cool to room temperature, the volatile components were removed under reduced pressure and the residue was purified by silica gel column Chromatography (eluent petroleum ether (60-90 ° C) / ethyl acetate, v / v = 30: 1) gave To a yellow liquid product 4a (1.52 g, yield 81percent). The target product passes the nuclear magnetic resonance spectrum Confirmed. |
[ 73387-52-7 ]
5-(4-Bromophenyl)-1-methyl-1H-pyrazole
Similarity: 0.82
[ 1125828-26-3 ]
1-(2-Bromo-5-chlorophenyl)-3-methyl-1H-pyrazole
Similarity: 0.78
[ 1060812-84-1 ]
5-Bromopyrazolo[1,5-a]pyridine
Similarity: 0.88
[ 1095539-84-6 ]
6-Bromo-1,3-dimethyl-1H-indazole
Similarity: 0.85
[ 73387-52-7 ]
5-(4-Bromophenyl)-1-methyl-1H-pyrazole
Similarity: 0.82
[ 73387-52-7 ]
5-(4-Bromophenyl)-1-methyl-1H-pyrazole
Similarity: 0.82
[ 1125828-26-3 ]
1-(2-Bromo-5-chlorophenyl)-3-methyl-1H-pyrazole
Similarity: 0.78
[ 852227-87-3 ]
1-(1,3-Dimethyl-1H-pyrazol-5-yl)-N-methylmethanamine
Similarity: 0.73